The 20 Best Neurotoxicity Syndromes Doctors Near Me in Bronx, NY

The maturation of GABAA receptor-mediated signaling from depolarizing to inhibitory is an age-related process controlled by cation chloride cotransporters, such as KCC2. As a result, GABA exerts dual functions, being an important neurotrophic factor during early development and the principal inhibitory neurotransmitter of the mature central nervous system. In our laboratory we have been investigating the age and mechanisms through which early life stressors and seizures may disrupt the normal patterns of brain development, by disrupting the neurotrophic effects of GABA. We are also studying methods to reverse these adverse processes. Furthermore, we are very interested in understanding how epileptogenesis proceeds in the developing brain and what is the specific role of GABAA receptors in this process. Dr. Galanopoulou is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses West Syndrome, Spasmus Nutans, Post-Traumatic Epilepsy, and Epilepsy.

Raminder Parihar, MD, is Director, Neuromodulation at Montefiore Einstein and Assistant Professor, Neurology at our Albert Einstein College of Medicine. Dr. Parihar evaluates and treats patients with different movement disorders. She is also largely involved in evaluating patients for candidacy for deep brain stimulation (DBS) surgery for the treatment of different movement disorders and initiating and following up stimulation programming. Dr. Parihar is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Movement Disorders, Parkinson's Disease, Essential Tremor, Drug Induced Dyskinesia, and Deep Brain Stimulation.

Solomon L. Moshé, MD, is Vice Chair of Neurology, Director of the Isabelle Rapin Child Neurology Division and Director of Clinical Neurophysiology at Montefiore. He is also the Charles Frost Chair in Neurosurgery and Neurology, Vice Chair, Saul R. Korey Department of Neurology, and Professor of Neurology, Neuroscience and Pediatrics at the Albert Einstein College of Medicine (Einstein). Dr. Moshé’s clinical focus is on epilepsy and electroencephalography with special emphasis on age-related influences on the expression, control and consequences of seizures. Dr. Moshe is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses West Syndrome, Spasmus Nutans, Post-Traumatic Epilepsy, and Epilepsy.

Paul F. Kent finished his undergraduate studies at the St. Lawrence University, followed by a combined MD/Ph.D. program at SUNY Upstate Medical University, with a doctorate in physiology. He was a resident and chief resident in Neurology, and completed his fellowship in Epilepsy/EEG at the SUNY Upstate Medical University. As an associate professor of neurology at SUNY Upstate Medical University, he was the Director of Neurophysiologic Intraoperative Monitoring. Since 2015, he has been an attending neurologist at the Columbia Comprehensive Epilepsy Center and Neurophysiologic Intraoperative Monitoring Program. His research interests include developing optical imaging techniques for the Operating Room to image cortical function and epileptic activity. Dr. Kent is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Seizures, Memory Loss, Autosomal Dominant Partial Epilepsy with Auditory Features, and Generalized Tonic-Clonic Seizure. Dr. Kent is board certified in Neurology, Clinical Neurophysiology, and Epilepsy. Dr. Kent is currently accepting new patients.

Mitchell Shear is a primary care provider, practicing in Internal Medicine in Bronx, New York. Dr. Shear is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Sepsis, Asthma in Children, Asthma, Gastrostomy, and Endoscopy.

Dr. Igor Zilberman, MD is an Assistant Professor of Neurology in the Division of Hospitalist and Critical Care Neurology. After medical school at SUNY Downstate Medical Center, Dr. Zilberman completed neurology residency at Mount Sinai Hospital, followed by fellowship training in Clinical Neurophysiology at SUNY Stony Brook Medical Center. Dr. Zilberman remained at SUNY Stony Brook as an attending, later transferring to Hackensack University Medical Center. Dr. Zilberman is board certified in Neurology, Clinical Neurophysiology, and Sleep Medicine, and his clinical interests include stroke, encephalopathy, and emergency neurology. He will be practicing as a neurohospitalist at The Allen Hospital of NewYork-Presbyterian. Dr. Zilberman is rated as an Advanced provider by MediFind in the treatment of Neurotoxicity Syndromes. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Stroke, Neurotoxicity Syndromes, Primary Familial Brain Calcification, and Cerebelloolivary Atrophy. Dr. Zilberman is board certified in Neurology, Sleep Medicine, and Clinical Neurophysiology.

David Eidelberg is a Neurologist practicing medicine in Manhasset, New York. Dr. Eidelberg is rated as an Advanced provider by MediFind in the treatment of Neurotoxicity Syndromes. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Cerebellar Multiple System Atrophy, Drug Induced Dyskinesia, and Deep Brain Stimulation. Dr. Eidelberg is board certified in American Board Of Psychiatry/Neurology-Neurology.

Jordan Schecter is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Schecter is rated as an Advanced provider by MediFind in the treatment of Neurotoxicity Syndromes. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Neurotoxicity Syndromes, and Plasmacytoma.

Gurcharanjeet Kaur, MD is an assistant professor of neurology at CUIMC, in the Division of Child Neurology. Dr. Kaur is a graduate of Lady Hardinge Medical College in New Delhi, India. She completed residency in both pediatric neurology and neuro-oncology at Stony Brook University Medical Center and Memorial Sloan Kettering Cancer Center, respectively. Dr. Kaur is a board-certified child neurologist and pediatric neuro-oncologist, with particular expertise in neurofibromatosis (NF) and NF-related tumors, cancer related neurotoxicity, and tumor targeted therapy for low grade gliomas. Dr. Kaur is dedicated to helping children while minimizing the toxicities and residual deficits by providing the highest quality of care and access to recent advances in the field. Dr. Kaur remains committed to clinical and pre-clinical research. She has been involved in the clinical trials as a site principal investigator and co-investigator. She mentors’ residents, fellows, and medical students interested in the field of child neurology and neuro-oncology. Dr. Kaur is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Seizures, and Zika Virus Disease. Dr. Kaur is currently accepting new patients.

Dr. Sarah Flanagan Wesley graduated from medical school at the Royal College of Surgeons in Dublin, followed by residency in adult neurology at the Icahn School of Medicine at Mount Sinai and then fellowship in neuroimmunology at the Yale School of Medicine. Dr. Wesley was on faculty at Yale as an Assistant Professor of Neurology in the neuroimmunology subdivision until joining faculty at Columbia in 2020. Dr. Wesley treats a range of neuroimmunological and autoimmune neurological conditions, including various forms of autoimmune encephalitis, CNS vasculitis, neuro-rheumatological conditions, multiple sclerosis, and immune-related toxicity to cancer treatments. Dr. Wesley serves as a lead for Columbia's neurological immunotoxicity program, conducting clinical and translational research on the mechanisms and management of neurological side effects to cancer treatments, such as cancer immune checkpoint inhibitors and CAR T-cell therapy. Dr. Wesley is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Encephalitis, Anti-NMDA Receptor Encephalitis, Rasmussen Encephalitis, and Multiple Sclerosis (MS). Dr. Wesley is board certified in Neurology. Dr. Wesley is currently accepting new patients.

Dr. Przedborski's academic interests focus on the molecular and cellular biology of neurodegenerative disorders such as Parkinson's disease (PD) and Amyotrophic Lateral Sclerosis (ALS). His ongoing research aims at understanding the contributions of cell-autonomous and non cell-autonomous mechanisms to neurodegeneration using both toxic and genetic experimental models of PD and ALS. In keeping with this goal, how alterations in mitochondrial biology, especially of mitochondrial dynamics and mitophagy, provoke degeneration of specific subpopulations of neurons is one of the main areas of research in the Przedborski laboratory. To what extent and by which mechanisms do non-neuronal cells, like microglia and astrocytes, participate in the demise of neurons in neurodegenerative disorders, such as PD and ALS, represent a second main line of research in this laboratory.These research efforts are supported by federal grants from both NIH and the DoD as well as by several private agencies such as the Parkinson's Disease Foundation and the Thomas Hartman Foundation. Dr. Przedborski is a Senior Editor for the Journal of Neuroscience and an Associate Editor of Movement Disorders. He also serves as an ad hoc Reviewer for the National Institutes of Health, the Veterans Adminsration, the Department of Defense, the Canadian Medical Research Council, and various medical journals including Science, Nature, Nature Neuroscience, Neuron, the New England Journal of Medicine, and the Proceedings of the National Academy of Science USA. Dr. Przedborski is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Parkinson's Disease, and Movement Disorders.

Daniel Talmasov, MD, is a board-certified neurologist and psychiatrist in the Division of Aging and Dementia at Columbia University Irving Medical Center. After earning his M.D. at Stony Brook University, Dr. Talmasov completed his residency in psychiatry at Brigham and Women's Hospital / Harvard Medical School, followed by residency in neurology at NYU Langone / Bellevue Hospital Center, where he also served as chief resident. Dr. Talmasov then completed advanced training in Behavioral Neurology & Neuropsychiatry at Columbia University Irving Medical Center. Dr. Talmasov specializes in the treatment of patients with behavioral, cognitive, and emotional symptoms of neurodegenerative disease, including Frontotemporal Dementia and related disorders. He also provides neurobehavioral consultation for patients in the Eleanor and Lou Gehrig ALS Center and the Huntington's Disease Society Center of Excellence at Columbia. Dr. Talmasov is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. His clinical expertise encompasses Transient Global Amnesia, Subarachnoid Hemorrhage, Hemangioblastoma, and Alzheimer's Disease. Dr. Talmasov is board certified in Psychiatry and Neurology. Dr. Talmasov is currently accepting new patients.

Dr. Yuan Ji is a board-certified neurologist with a subspecialty certification in Headache Medicine. She focuses on the diagnosis and management of complex headache disorders. Dr. Ji earned her medical degree from the New York University School of Medicine and completed her neurology residency at NYU Langone Medical Center. She then completed a fellowship at the Montefiore Headache Center. Dr. Ji is passionate about patient-centered care and medical education. She became interested in headache medicine as a medical student and has been fascinated by the complexity of the brain and the challenges of treating neurological disorders. What drew her to the field of headache was the combination of evidence-based therapies and a holistic approach that requires continued collaboration to develop personalized treatment plans. Because headache disorders often result in a significant impact on many aspects of patients' daily lives, she finds it deeply rewarding to work with patients and help them improve their quality of life. Dr. Ji is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. Her clinical expertise encompasses Multiple Pterygium Syndrome, Thanatophoric Dysplasia, Chromosome 2 Uniparental Disomy, and PIK3CA-Related Overgrowth Spectrum. Dr. Ji is board certified in Headache Medicine. Dr. Ji is currently accepting new patients.

Michael Pardo is a primary care provider, practicing in Internal Medicine and Hospital Medicine in New York, New York. He has been practicing medicine for over 10 years. Dr. Pardo is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. His clinical expertise encompasses Pneumonia, Sickle Cell Disease, Nasal Flaring, and Osteonecrosis.

Prasanta Basak is a primary care provider, practicing in Internal Medicine in New Rochelle, New York. Dr. Basak is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Osteomyelitis in Children, Cellulitis, Thyrotoxic Periodic Paralysis, Gastrostomy, and Colonoscopy.

Bibhuti Mishra is a Neurologist and a Sleep Medicine provider practicing medicine in Rego Park, New York. Dr. Mishra is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Acute Cerebellar Ataxia, Supranuclear Ocular Palsy, Supranuclear Ophthalmoplegia, and Progressive Supranuclear Palsy Atypical. Dr. Mishra is board certified in American Board Of Psychiatry/Neurology-Neurology and American Board Of Psychiatry & Neurology-Neurophysiology.

Bianca Santomasso is a Neurologist practicing medicine in New York, New York. She has been practicing medicine for over 18 years. Dr. Santomasso is rated as a Distinguished provider by MediFind in the treatment of Neurotoxicity Syndromes. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Neurotoxicity Syndromes, Primary Lymphoma of the Brain, Brain Tumor, and Metastatic Brain Tumor. Dr. Santomasso is currently accepting new patients.

Jason Cohen is a Neurologist practicing medicine in Yonkers, New York. Dr. Cohen is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Memory Loss, Cerebellar Degeneration, Neurotoxicity Syndromes, and Dementia.

Neeraj Singh is a Neurologist practicing medicine in Great Neck, New York. Dr. Singh is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Corticobasal Degeneration, Seizures, Cerebellar Degeneration, and Neuronal Intranuclear Inclusion Disease (NIID).

Martin Niethammer is a Neurologist practicing medicine in Great Neck, New York. Dr. Niethammer is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Drug Induced Dyskinesia, REM Behavior Disorder, and Deep Brain Stimulation. Dr. Niethammer is board certified in American Board Of Psychiatry/Neurology-Neurology.